Abstract

Glioblastoma (GBM) is the most aggressive and common malignant brain tumour in adults. A well-known hallmark of GMB and many other tumours is aerobic glycolysis. MicroRNAs (miRNAs) are a class of short nonprotein coding sequences that exert posttranscriptional controls on gene expression and represent critical regulators of aerobic glycolysis in GBM. In GBM, miRNAs regulate the expression of glycolytic genes directly and via the regulation of metabolism-associated tumour suppressors and oncogenic signalling pathways. This review aims to establish links between miRNAs expression levels, the expression of GBM glycolytic regulatory genes, and the malignant progression and prognosis of GBM. In this review, the involvement of 25 miRNAs in the regulation of glycolytic metabolism of GBM is discussed. Seven of these miRNAs have been shown to regulate glycolytic metabolism in other tumour types. Further eight miRNAs, which are differentially expressed in GBM, have also been reported to regulate glycolytic metabolism in other cancer types. Thus, these miRNAs could serve as potential glycolytic regulators in GBM but will require functional validation. As such, the characterisation of these molecular and metabolic signatures in GBM can facilitate a better understanding of the molecular pathogenesis of this disease.

Highlights

  • Glioblastoma (GBM) is the most common malignant primary brain tumour in adults, accounting for 12–15% of all intracranial tumours [1]

  • The current GBM treatment standards consist of maximal surgical resection followed by radiotherapy with concurrent temozolomide (TMZ) chemotherapy, followed by six cycles of maintenance TMZ chemotherapy [7, 8]

  • This review aims to establish links between miRNAs expression levels, the expression of GBM glycolytic regulators and the malignant progression and prognosis of GBM

Read more

Summary

Review Article MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma

Children’s Brain Tumour Research Centre, Queen’s Medical Centre, D22 Medical School, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK. MicroRNAs (miRNAs) are a class of short nonprotein coding sequences that exert posttranscriptional controls on gene expression and represent critical regulators of aerobic glycolysis in GBM. The involvement of 25 miRNAs in the regulation of glycolytic metabolism of GBM is discussed. Seven of these miRNAs have been shown to regulate glycolytic metabolism in other tumour types. Further eight miRNAs, which are differentially expressed in GBM, have been reported to regulate glycolytic metabolism in other cancer types. These miRNAs could serve as potential glycolytic regulators in GBM but will require functional validation. The characterisation of these molecular and metabolic signatures in GBM can facilitate a better understanding of the molecular pathogenesis of this disease

Introduction
PDH Improved
Acetyl coenzyme A
Upregulation of glycolysis
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call